Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891330311> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W2891330311 endingPage "32" @default.
- W2891330311 startingPage "27" @default.
- W2891330311 abstract "There is evidence of the effectiveness of rituximab in treatment of nephrotic syndrome in children. The present study aimed to assess safety and the therapeutic effectiveness of rituximab in steroid- and cyclosporine-resistant pediatric nephrotic syndrome.Forty-three children with steroid- and cyclosporine-resistant or steroid- and cyclosporine-dependent noncongenital nephrotic syndrome were included in the study to receive intravenous rituximab, 375 mg/m2/wk, for 4 weeks. The children were followed up for 2 years. Effectiveness was defined as remission of proteinuria in response to rituximab. Side effects of rituximab were monitored.Overall, 23 (57.1%) of the children had steroid- and cyclosporine-resistant nephrotic syndrome, of whom 8 (34.8%) revealed complete response and 3 (13%) revealed partial response. Seven children (16.7%) had late-resistant nephrotic syndrome, of whom 6 (85.7%) revealed complete response and none revealed partial response. Ten children (26.2%) had steroid- and cyclosporine-dependence all of whom revealed complete response to rituximab. Complete response rate was significantly higher in those with drug-dependent pattern than the other groups (P = .002). There was no association between response to rituximab and pathological basis of disease. Side effects were found in 4 patients as leukopenia in 2, alopecia in 1, and eosinophilia in 1.Rituximab is effective for children with nephrotic syndrome with high efficacy and well tolerability, especially in those with steroid- and cyclosporine-dependent nephrotic syndrome." @default.
- W2891330311 created "2018-09-27" @default.
- W2891330311 creator A5006637739 @default.
- W2891330311 creator A5011241773 @default.
- W2891330311 creator A5037237627 @default.
- W2891330311 creator A5049917063 @default.
- W2891330311 creator A5053107483 @default.
- W2891330311 creator A5061194080 @default.
- W2891330311 creator A5086784321 @default.
- W2891330311 creator A5087302228 @default.
- W2891330311 date "2018-01-01" @default.
- W2891330311 modified "2023-09-23" @default.
- W2891330311 title "Efficacy and Safety of Rituximab in Children With Steroid- and Cyclosporine-resistant and Steroid- and Cyclosporine-dependent Nephrotic Syndrome." @default.
- W2891330311 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29421774" @default.
- W2891330311 hasPublicationYear "2018" @default.
- W2891330311 type Work @default.
- W2891330311 sameAs 2891330311 @default.
- W2891330311 citedByCount "6" @default.
- W2891330311 countsByYear W28913303112019 @default.
- W2891330311 countsByYear W28913303112021 @default.
- W2891330311 countsByYear W28913303112022 @default.
- W2891330311 countsByYear W28913303112023 @default.
- W2891330311 crossrefType "journal-article" @default.
- W2891330311 hasAuthorship W2891330311A5006637739 @default.
- W2891330311 hasAuthorship W2891330311A5011241773 @default.
- W2891330311 hasAuthorship W2891330311A5037237627 @default.
- W2891330311 hasAuthorship W2891330311A5049917063 @default.
- W2891330311 hasAuthorship W2891330311A5053107483 @default.
- W2891330311 hasAuthorship W2891330311A5061194080 @default.
- W2891330311 hasAuthorship W2891330311A5086784321 @default.
- W2891330311 hasAuthorship W2891330311A5087302228 @default.
- W2891330311 hasConcept C126322002 @default.
- W2891330311 hasConcept C197934379 @default.
- W2891330311 hasConcept C203014093 @default.
- W2891330311 hasConcept C2778375690 @default.
- W2891330311 hasConcept C2778930706 @default.
- W2891330311 hasConcept C2779338263 @default.
- W2891330311 hasConcept C2779561371 @default.
- W2891330311 hasConcept C2780091579 @default.
- W2891330311 hasConcept C2780653079 @default.
- W2891330311 hasConcept C71924100 @default.
- W2891330311 hasConcept C90924648 @default.
- W2891330311 hasConceptScore W2891330311C126322002 @default.
- W2891330311 hasConceptScore W2891330311C197934379 @default.
- W2891330311 hasConceptScore W2891330311C203014093 @default.
- W2891330311 hasConceptScore W2891330311C2778375690 @default.
- W2891330311 hasConceptScore W2891330311C2778930706 @default.
- W2891330311 hasConceptScore W2891330311C2779338263 @default.
- W2891330311 hasConceptScore W2891330311C2779561371 @default.
- W2891330311 hasConceptScore W2891330311C2780091579 @default.
- W2891330311 hasConceptScore W2891330311C2780653079 @default.
- W2891330311 hasConceptScore W2891330311C71924100 @default.
- W2891330311 hasConceptScore W2891330311C90924648 @default.
- W2891330311 hasIssue "1" @default.
- W2891330311 hasLocation W28913303111 @default.
- W2891330311 hasOpenAccess W2891330311 @default.
- W2891330311 hasPrimaryLocation W28913303111 @default.
- W2891330311 hasRelatedWork W1487881706 @default.
- W2891330311 hasRelatedWork W1985654865 @default.
- W2891330311 hasRelatedWork W2003607385 @default.
- W2891330311 hasRelatedWork W2022862734 @default.
- W2891330311 hasRelatedWork W2041581457 @default.
- W2891330311 hasRelatedWork W2159732018 @default.
- W2891330311 hasRelatedWork W2571795535 @default.
- W2891330311 hasRelatedWork W2582100433 @default.
- W2891330311 hasRelatedWork W2609470035 @default.
- W2891330311 hasRelatedWork W2995343154 @default.
- W2891330311 hasVolume "12" @default.
- W2891330311 isParatext "false" @default.
- W2891330311 isRetracted "false" @default.
- W2891330311 magId "2891330311" @default.
- W2891330311 workType "article" @default.